✦ LIBER ✦

Liraglutide + Metformin Combination Therapy in Type 2 Diabetes: Clinical Benefits Associated with Early Use of Liraglutide and with Switching a Sulfonylurea for Liraglutide

✍ Scribed by Bowering, Keith; Bain, Stephen C.; Seufert, Jochen; Thomsen, Anne B.; Furber, Sabina; D'alessio, David

Book ID: 122996082
Publisher: Canadian Diabetes Association
Year: 2012
Tongue: English
Weight: 49 KB
Volume: 36
Category: Article
ISSN: 1499-2671
DOI: 10.1016/j.jcjd.2012.07.360

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Liraglutide+metformin in type 2 diabetes

Liraglutide+metformin in type 2 diabetes: clinical benefits with early use of liraglutide and switch from sulphonylurea

✍ Svendsen, C.; Bain, S.C.; Seufert, J.; Thomsen, A. Bloch; D’Alessio, D. 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 54 KB

Efficacy and Safety Comparison of Liragl

Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes: The LEAD (Liraglutide Effect and Action in Diabetes)-2 study

✍ Nauck, M.; Frid, A.; Hermansen, K.; Shah, N. S.; Tankova, T.; Mitha, I. H.; Zdra 📂 Article 📅 2008 🏛 American Diabetes Association 🌐 English ⚖ 358 KB

Combination therapy with liraglutide and

Combination therapy with liraglutide and sulfonylurea for a type 2 diabetic patient with high titer of anti-insulin antibodies produced by insulin therapy

✍ Masanori Yoshida; Masato Asai; Misaki Miyata; Koichiro Ogawa; Harumi Maeda; Yuta 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Liraglutide vs insulin glargine and plac

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

✍ D. Russell-Jones; A. Vaag; O. Schmitz; B. K. Sethi; N. Lalic; S. Antic; M. Zdrav 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 193 KB

PDB50 Long-Term Clinical and Economic Be

PDB50 Long-Term Clinical and Economic Benefit Associated with Liraglutide Versus Sitagliptin Therapy When Added to Metformin in the Treatment of Type 2 Diabetes: a Core Diabetes Model Study

✍ W.C. Lee; Y. Samyshkin; J. Langer; J.L. Palmer 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Long-term clinical and economic outcomes

Long-term clinical and economic outcomes associated with liraglutide versus sitagliptin therapy when added to metformin in the treatment of type 2 diabetes: a CORE Diabetes Model analysis

✍ Lee, Won Chan; Samyshkin, Yevgeniy; Langer, Jakob; Palmer, James L. 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 279 KB